Literature DB >> 9643849

Zafirlukast and Churg-Strauss syndrome.

R W Honsinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9643849

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?

Authors:  M E Wechsler; R Pauwels; J M Drazen
Journal:  Drug Saf       Date:  1999-10       Impact factor: 5.606

2.  Safety of zafirlukast: results of a postmarketing surveillance study on 7976 patients in England.

Authors:  Beverley R Twaites; Lynda V Wilton; Saad A W Shakir
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 3.  Benefit-risk assessment of antileukotrienes in the management of asthma.

Authors:  Luis García-Marcos; Antje Schuster; Eduardo G Pérez-Yarza
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.